Birgit Girshick's Insider Trades & SAST Disclosures
Birgit Girshick's most recent trade in Charles River Laboratories International Inc. was a trade of 430 Common Stock done . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Birgit Girshick.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2025 | 430 | 54,628 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Purchase of securities on an exchange or from another person at price $ 164.63 per share. | 20 Feb 2025 | 1,514 | 55,058 (0%) | 0% | 164.6 | 249,250 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 4,057 | 54,569 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.57 per share. | 31 Jan 2025 | 1,025 | 53,544 (0%) | 0% | 165.6 | 169,709 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 8,722 | 8,722 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 3,838 | 50,512 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.51 per share. | 29 May 2024 | 216 | 46,674 (0%) | 0% | 214.5 | 46,334 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 376 | 47,264 (0%) | 0% | 217.2 | 81,671 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 242 | 47,022 (0%) | 0% | 217.2 | 52,565 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 132 | 46,890 (0%) | 0% | 217.2 | 28,672 | Common Stock |
| Charles River Laboratories... | Girshick Birgit | Corporate Executive VP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2024 | 424 | 47,691 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,526 | 49,274 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,451 | 49,199 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Girshick Birgit | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 1,159 | 48,115 (0%) | 0% | 220.3 | 255,305 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 1,135 | 48,064 (0%) | 0% | 220.3 | 250,018 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 10 Jan 2024 | 5,916 | 50,365 (0%) | 0% | 144.7 | 855,868 | Common Stock |
| Charles River Laboratories... | Girshick Birgit | Corporate Executive VP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 5,916 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 213.14 per share. | 10 Jan 2024 | 4,617 | 45,748 (0%) | 0% | 213.1 | 984,067 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 9,145 | 9,145 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 3,812 | 44,067 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 242 | 43,825 (0%) | 0% | 194.1 | 46,977 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 216 | 43,477 (0%) | 0% | 194.1 | 41,930 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 132 | 43,693 (0%) | 0% | 194.1 | 25,624 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2023 | 475 | 40,255 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.60 per share. | 22 Feb 2023 | 308 | 40,730 (0%) | 0% | 243.6 | 75,029 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,205 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.34 per share. | 16 Feb 2023 | 3,205 | 44,243 (0%) | 0% | 109.3 | 350,435 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 255.65 per share. | 16 Feb 2023 | 1,392 | 41,540 (0%) | 0% | 255.7 | 355,870 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 256.48 per share. | 16 Feb 2023 | 502 | 41,038 (0%) | 0% | 256.5 | 128,751 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 254.55 per share. | 16 Feb 2023 | 417 | 42,932 (0%) | 0% | 254.5 | 106,147 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 253.78 per share. | 16 Feb 2023 | 219 | 43,349 (0%) | 0% | 253.8 | 55,578 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 251.56 per share. | 16 Feb 2023 | 183 | 43,725 (0%) | 0% | 251.6 | 46,035 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 252.87 per share. | 16 Feb 2023 | 157 | 43,568 (0%) | 0% | 252.9 | 39,700 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 248.07 per share. | 16 Feb 2023 | 100 | 44,059 (0%) | 0% | 248.1 | 24,807 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 246.13 per share. | 16 Feb 2023 | 84 | 44,159 (0%) | 0% | 246.1 | 20,675 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 250.69 per share. | 16 Feb 2023 | 78 | 43,908 (0%) | 0% | 250.7 | 19,554 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Sale of securities on an exchange or to another person at price $ 249.22 per share. | 16 Feb 2023 | 73 | 43,986 (0%) | 0% | 249.2 | 18,193 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 8,435 | 44,191 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.29 per share. | 27 Jan 2023 | 3,153 | 41,038 (0%) | 0% | 244.3 | 770,246 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 6,634 | 6,634 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,455 | 36,124 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 218 | 35,756 (0%) | 0% | 244.4 | 53,281 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 150 | 35,974 (0%) | 0% | 244.4 | 36,662 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.58 per share. | 22 Feb 2022 | 280 | 33,669 (0%) | 0% | 289.6 | 81,082 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.61 per share. | 22 Feb 2022 | 274 | 33,949 (0%) | 0% | 293.6 | 80,449 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2021 | 11,029 | 38,100 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.24 per share. | 23 Sep 2021 | 3,877 | 34,223 (0%) | 0% | 312.2 | 1,210,554 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Sep 2021 | 531 | 27,071 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 439.90 per share. | 13 Sep 2021 | 2,344 | 27,602 (0%) | 0% | 439.9 | 1,031,126 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 442.15 per share. | 13 Sep 2021 | 72 | 29,953 (0%) | 0% | 442.2 | 31,835 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 442.71 per share. | 13 Sep 2021 | 7 | 29,946 (0%) | 0% | 442.7 | 3,099 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 441.50 per share. | 13 Sep 2021 | 2 | 30,025 (0%) | 0% | 441.5 | 883 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,659 | 3,659 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 1,183 | 30,243 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.99 per share. | 28 May 2021 | 216 | 30,027 (0%) | 0% | 338.0 | 73,006 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 6,409 | 3,205 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 304.85 per share. | 05 Apr 2021 | 6,409 | 29,060 (0%) | 0% | 304.9 | 1,953,784 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.34 per share. | 05 Apr 2021 | 6,409 | 35,469 (0%) | 0% | 109.3 | 700,760 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 5,986 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 298.00 per share. | 05 Apr 2021 | 5,986 | 29,060 (0%) | 0% | 298 | 1,783,828 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.05 per share. | 05 Apr 2021 | 5,986 | 35,046 (0%) | 0% | 88.0 | 527,067 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 05 Apr 2021 | 5,916 | 34,976 (0%) | 0% | 144.7 | 855,868 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 5,916 | 5,916 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 304.85 per share. | 05 Apr 2021 | 5,916 | 29,060 (0%) | 0% | 304.9 | 1,803,493 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 999 | 5,986 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 298.00 per share. | 05 Apr 2021 | 999 | 29,060 (0%) | 0% | 298 | 297,702 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.05 per share. | 05 Apr 2021 | 999 | 30,059 (0%) | 0% | 88.1 | 87,962 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Purchase of securities on an exchange or from another person at price $ 187.82 per share. | 01 Mar 2021 | 1,322 | 44,449 (0%) | 0% | 187.8 | 248,298 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2021 | 350 | 28,710 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 282.98 per share. | 24 Feb 2021 | 322 | 29,060 (0%) | 0% | 283.0 | 91,120 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,675 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 293.92 per share. | 19 Feb 2021 | 1,675 | 30,005 (0%) | 0% | 293.9 | 492,311 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.70 per share. | 19 Feb 2021 | 1,675 | 31,680 (0%) | 0% | 73.7 | 123,448 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.59 per share. | 19 Feb 2021 | 315 | 29,382 (0%) | 0% | 283.6 | 89,331 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.55 per share. | 19 Feb 2021 | 308 | 29,697 (0%) | 0% | 289.5 | 89,181 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 11,862 | 34,714 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 260.88 per share. | 29 Jan 2021 | 4,709 | 30,005 (0%) | 0% | 260.9 | 1,228,484 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 213.51 per share. | 20 Aug 2020 | 933 | 22,852 (0%) | 0% | 213.5 | 199,205 | Common Stock |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 6,500 | 6,500 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 1,948 | 23,785 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Birgit Girshick | Corporate Executive VP | Sale of securities on an exchange or to another person at price $ 165.74 per share. | 12 May 2020 | 780 | 21,837 (0%) | 0% | 165.7 | 129,277 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges